The DOI matches its Crossref record; 78 of the 78 references it cites were found in a registry or an index.
The Hippo/ YAP pathway interacts with EGFR signaling and HPV oncoproteins to regulate cervical cancer progression
Open accessAbstract
The Hippo signaling pathway controls organ size and tumorigenesis through a kinase cascade that inactivates Yes-associated protein (YAP). Here, we show that YAP plays a central role in controlling the progression of cervical cancer. Our results suggest that YAP expression is associated with a poor prognosis for cervical cancer. TGF-α and amphiregulin (AREG), via EGFR, inhibit the Hippo signaling pathway and activate YAP to induce cervical cancer cell proliferation and migration. Activated YAP allows for up-regulation of TGF-α, AREG, and EGFR, forming a positive signaling loop to drive cervical cancer cell proliferation. HPV E6 protein, a major etiological molecule of cervical cancer, maintains high YAP protein levels in cervical cancer cells by preventing proteasome-dependent YAP degradation to drive cervical cancer cell proliferation. Results from human cervical cancer genomic databases and an accepted transgenic mouse model strongly support the clinical relevance of the discovered feed-forward signaling loop. Our study indicates that combined targeting of the Hippo and the ERBB signaling pathways represents a novel therapeutic strategy for prevention and treatment of cervical cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., et al. (2007) · Genes & Development · doi:10.1101/gad.1602907 · Cited by 3,092 · cited 1×
“Keywords cervical cancer; EGFR; Hippo; HPV; YAP Subject Categories Cancer; Urogenital System DOI 10.15252/emmm.201404976 | Received 19 December 2014 | Revised 18 August 2015 | Accepted 20 August 2015 | Published online 28 September 2015 EMBO Mol Med (2015) 7: 1426–1449”
BackgroundInfluentialThe human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene product
Dyson, N., Howley, P. M., Münger, K., & Harlow, E. (1989) · Science · doi:10.1126/science.2537532 · Cited by 3,017 · cited 1×
“It is believed that the high-risk HPV oncoproteins, E6 and E7, contribute to cervical carcinogenesis by inactivating the cellular tumor suppressor proteins p53 and pRb, respectively (Dyson et al, 1989; Scheffner et al, 1990; Boyer et al, 1996).”
BackgroundHuman papillomavirus and cervical cancer
Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 2,985
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Self-citationThe Hippo Signaling Pathway in Development and Cancer
Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.011 · Cited by 2,269
Spheroid-based drug screen: Considerations and practical approach
Friedrich, J., Seidel, C., Ebner, R., & Kunz-Schughart, L. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.226 · Cited by 1,742
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF β-TRCP
Zhao, B., Li, L., Tumaneng, K., Wang, C.-Y., & Guan, K.-L. (2010) · Genes & Development · doi:10.1101/gad.1843810 · Cited by 1,418
Self-citationThe Hippo pathway: regulators and regulations.
Yu, F.-X., & Guan, K.-L. (2013) · Genes & Development · doi:10.1101/gad.210773.112 · Cited by 1,231
Epidemiology of Genital Human Papillomavirus Infection
Koutsky, P. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00177-0 · Cited by 1,107
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Transforming properties of YAP , a candidate oncogene on the chromosome 11q22 amplicon
Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C.-X., Brugge, J. S., & Haber, D. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605579103 · Cited by 885
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.026 · Cited by 757
EPIDEMIOLOGY OF GENITAL HUMAN PAPILLOMAVIRUS INFECTION
KOUTSKY, L. A., GALLOWAY, D. A., & HOLMES, K. K. (1988) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036020 · Cited by 711
Castellsagué, X., Díaz, M., de Sanjosé, S., Muñoz, N., Herrero, R., Franceschi, S., Peeling, R. W., Ashley, R., Smith, J. S., Snijders, P. J. F., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj067 · Cited by 688
Sigismund, S., Argenzio, E., Tosoni, D., Cavallaro, E., Polo, S., & Di Fiore, P. P. (2008) · Developmental Cell · doi:10.1016/j.devcel.2008.06.012 · Cited by 679
Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines.
Yee, C., Krishnan-Hewlett, I., Baker, C. C., Schlegel, R., & Howley, P. M. (1985) · PubMed · Cited by 677
The Hippo signaling pathway in stem cell biology and cancer
Mo, J., Park, H. W., & Guan, K. (2014) · EMBO reports · doi:10.15252/embr.201438638 · Cited by 674
Absence of HeLa Cell Contamination in 169 Cell Lines Derived From Human Tumors2
Fogh, J., Wright, W. C., & Loveless, J. D. (1977) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/58.2.209 · Cited by 663
A gp130–Src–YAP module links inflammation to epithelial regeneration
Taniguchi, K., Wu, L.-W., Grivennikov, S. I., de Jong, P. R., Lian, I., Yu, F.-X., Wang, K., Ho, S. B., Boland, B. S., Chang, J. T., et al. (2015) · Nature · doi:10.1038/nature14228 · Cited by 633
Feng, X., Degese, M. S., Iglesias-Bartolome, R., Vaque, J. P., Molinolo, A. A., Rodrigues, M., Zaidi, M. R., Ksander, B. R., Merlino, G., Sodhi, A., et al. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.04.016 · Cited by 563
Expression of Yes-associated protein in common solid tumors
Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., & Anders, R. A. (2008) · Human Pathology · doi:10.1016/j.humpath.2008.04.012 · Cited by 552
Self-citationYes‐associated protein is an independent prognostic marker in hepatocellular carcinoma
Xu, M. Z., Yao, T., Lee, N. P. Y., Ng, I. O. L., Chan, Y., Zender, L., Lowe, S. W., Poon, R. T. P., & Luk, J. M. (2009) · Cancer · doi:10.1002/cncr.24495 · Cited by 528
Lee, K.-P., Lee, J.-H., Kim, T.-S., Kim, T.-H., Park, H.-D., Byun, J.-S., Kim, M.-C., Jeong, W.-I., Calvisi, D. F., Kim, J.-M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912203107 · Cited by 493
Natural history of cervical squamous intraepithelial lesions: a meta-analysis*1
MELNIKOW, J. (1998) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(98)00245-2 · Cited by 435
Zhang, J., Ji, J.-Y., Yu, M., Overholtzer, M., Smolen, G. A., Wang, R., Brugge, J. S., Dyson, N. J., & Haber, D. A. (2009) · Nature Cell Biology · doi:10.1038/ncb1993 · Cited by 424
Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases
Marmor, M. D., & Yarden, Y. (2004) · Oncogene · doi:10.1038/sj.onc.1207390 · Cited by 383
Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., & Kenney, A. M. (2009) · Genes & Development · doi:10.1101/gad.1824509 · Cited by 377
Strano, S., Monti, O., Pediconi, N., Baccarini, A., Fontemaggi, G., Lapi, E., Mantovani, F., Damalas, A., Citro, G., Sacchi, A., et al. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.008 · Cited by 360
Wang, Y., Dong, Q., Zhang, Q., Li, Z., Wang, E., & Qiu, X. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01511.x · Cited by 343
Yes-associated protein (YAP) functions as a tumor suppressor in breast
Yuan, M., Tomlinson, V, Lara, R., Holliday, D., Chelala, C., Harada, T., Gangeswaran, R., Manson-Bishop, C., Smith, P., Danovi, S. A., et al. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.108 · Cited by 335
Fichorova, R. N., Rheinwald, J. G., & Anderson, D. J. (1997) · Biology of Reproduction · doi:10.1095/biolreprod57.4.847 · Cited by 313
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D. L., & Harvey, K. F. (2011) · Oncogene · doi:10.1038/onc.2011.8 · Cited by 309
Snijders, A. M., Schmidt, B. L., Fridlyand, J., Dekker, N., Pinkel, D., Jordan, R. C. K., & Albertson, D. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208601 · Cited by 280
Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene
Hall, C. A., Wang, R., Miao, J., Oliva, E., Shen, X., Wheeler, T., Hilsenbeck, S. G., Orsulic, S., & Goode, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1242 · Cited by 263
Kang, W., Tong, J. H. M., Chan, A. W. H., Lee, T.-L., Lung, R. W. M., Leung, P. P. S., So, K. K. Y., Wu, K., Fan, D., Yu, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2467 · Cited by 259
Goh, L. K., Huang, F., Kim, W., Gygi, S., & Sorkin, A. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001008 · Cited by 258
Brake, T., & Lambert, P. F. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409883102 · Cited by 236
Self-citationYAP is a candidate oncogene for esophageal squamous cell carcinoma
Muramatsu, T., Imoto, I., Matsui, T., Kozaki, K.-I., Haruki, S., Sudol, M., Shimada, Y., Tsuda, H., Kawano, T., & Inazawa, J. (2011) · Carcinogenesis · doi:10.1093/carcin/bgq254 · Cited by 227
Leung, C. Y., & Zernicka-Goetz, M. (2013) · Nature Communications · doi:10.1038/ncomms3251 · Cited by 203
Stoler, M. H., & Broker, T. R. (1986) · Human Pathology · doi:10.1016/s0046-8177(86)80569-x · Cited by 196
Fichorova, R. N., & Anderson, D. J. (1999) · Biology of Reproduction · doi:10.1095/biolreprod60.2.508 · Cited by 190
Wang, H.-K., Duffy, A. A., Broker, T. R., & Chow, L. T. (2009) · Genes & Development · doi:10.1101/gad.1735109 · Cited by 170
Shai, A., Brake, T., Somoza, C., & Lambert, P. F. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3344 · Cited by 158
Self-citationYAP oncogene overexpression supercharges colon cancer proliferation
Avruch, J., Zhou, D., & Bardeesy, N. M. (2012) · Cell Cycle · doi:10.4161/cc.11.6.19453 · Cited by 142
Human papillomavirus in a necessary cause of invasive cervical cancer worldwide
(1999) · Pure Amsterdam UMC · doi:10.1002/(sici)1096-9896(199909)189:1 · Cited by 140
Epidermal growth factor receptor as a biomarker for cervical cancer
Soonthornthum, T., Arias‐Pulido, H., Joste, N. E., Lomo, L. C., Muller, C. Y., Rutledge, T. L., & Verschraegen, C. F. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq723 · Cited by 127
Vaccines Against Human Papillomavirus and Cervical Cancer: Promises and Challenges
Mahdavi, A., & Monk, B. J. (2005) · The Oncologist · doi:10.1634/theoncologist.10-7-528 · Cited by 123
Opposing activities of the Ras and Hippo pathways converge on regulation of YAP protein turnover
Hong, X., Nguyen, H. T., Chen, Q., Zhang, R., Hagman, Z., Voorhoeve, P. M., & Cohen, S. M. (2014) · The EMBO Journal · doi:10.15252/embj.201489385 · Cited by 121
He, C., Lv, X., Hua, G., Lele, S. M., Remmenga, S. W., Dong, J., Davis, J. S., & Wang, C. (2015) · Oncogene · doi:10.1038/onc.2015.52 · Cited by 121
Self-citationYes-associated protein promotes tumour development in luminal epithelial derived breast cancer
Wang, X., Su, L., & Ou, Q. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.001 · Cited by 120
YAP regulates cell proliferation, migration, and steroidogenesis in adult granulosa cell tumors
Fu, Z., Lv, X., Hua, G., He, C., Dong, J., Lele, S. M., Li, D. W.-C., Zhai, Q.-L., Davis, J. S., & Wang, C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0339 · Cited by 117
Self-citationSome Properties of a New Epithelial Cell Line of Human Origin 2
SYKES, J. A., Whitescarver, J., Jernstrom, P. H., Nolan, J. F., & Byatt, P. (1970) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/45.1.107 · Cited by 115
Wang, C., Lv, X., He, C., Hua, G., Tsai, M.-Y., & Davis, J. S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.397 · Cited by 100
Self-citationAkerman, G. S., Tolleson, W. H., Brown, K. L., et al. (2001) · PubMed · Cited by 97
Elbel, M., Carl, S., Spaderna, S., & Iftner, T. (1997) · Virology · doi:10.1006/viro.1997.8860 · Cited by 97
Zehbe, I., Richard, C., DeCarlo, C. A., Shai, A., Lambert, P. F., Lichtig, H., Tommasino, M., & Sherman, L. (2008) · Virology · doi:10.1016/j.virol.2008.09.036 · Cited by 78
Self-citationSpangle, J. M., & Munger, K. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003237 · Cited by 76
Ubiquitylation in immune disorders and cancer: from molecular mechanisms to therapeutic implications
Fulda, S., Rajalingam, K., & Đikić, I. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201100707 · Cited by 74
Using an Immortalized Cell Line to Study the HPV Life Cycle in Organotypic
Lambert, P. F., Ozbun, M. A., Collins, A. S., Holmgren, S. C., Lee, D., & Nakahara, T. (2005) · Humana Press eBooks · doi:10.1385/1-59259-982-6:141 · Cited by 70
Self-citationNakagawa, S., Watanabe, S., Yoshikawa, H., Taketani, Y., Yoshiike, K., & Kanda, T. (1995) · Virology · doi:10.1006/viro.1995.1511 · Cited by 67
Beyond HPV: Oncomirs as new players in cervical cancer
Reshmi, G., & Pillai, M. R. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.11.011 · Cited by 59
Impact of the Human Papilloma Vaccine on Cervical Cancer
Chan, J. K., & Berek, J. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.8662 · Cited by 59
Kiyono, T., Hiraiwa, A., Ishii, S., Takahashi, T., & Ishibashi, M. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4656-4661.1994 · Cited by 58
Schrevel, M., Gorter, A., Kolkman-Uljee, S. M., et al. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.239 · Cited by 53
Wang, C., Lv, X., Jiang, C., Cordes, C. M., Fu, L., Lele, S. M., & Davis, J. S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048299 · Cited by 51
Self-citationSizemore, N., Choo, C. K., Eckert, R. L., & Rorke, E. A. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4179 · Cited by 46
Hergovich, A. (2012) · Breast Cancer Research · doi:10.1186/bcr3349 · Cited by 39
Expression of Yes-Associated Protein in Cervical Squamous Epithelium Lesions
Xiao, H., Wu, L., Zheng, H., Li, N., Wan, H., Liang, G., Zhao, Y., & Liang, J. (2014) · International Journal of Gynecological Cancer · doi:10.1097/igc.0000000000000259 · Cited by 37
Hwang, J. H., Pores‐Fernando, A. T., Faure, N., Andrabi, S., Hahn, W. C., Schaffhausen, B. S., & Roberts, T. M. (2014) · Journal of Virology · doi:10.1128/jvi.01399-14 · Cited by 26
Ishiwatari, H., Hayasaka, H., Inoue, H., Yutsudo, M., & Hakura, A. (1994) · Journal of Medical Virology · doi:10.1002/jmv.1890440306 · Cited by 19
(1996) · PubMed
Cited by
YAP/TAZ at the Roots of Cancer
Zanconato, F., Cordenonsi, M., & Piccolo, S. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.05.005 · Cited by 1,970
Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine
Dey, A., Varelas, X., & Guan, K.-L. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0070-z · Cited by 860
EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
Uribe, M. L., Marrocco, I., & Yarden, Y. (2021) · Cancers · doi:10.3390/cancers13112748 · Cited by 604
Verduci, L., Ferraiuolo, M., Sacconi, A., Ganci, F., Vitale, J., Colombo, T., Paci, P., Strano, S., Macino, G., Rajewsky, N., et al. (2017) · Genome Biology · doi:10.1186/s13059-017-1368-y · Cited by 267
Key Molecular Events in Cervical Cancer Development
Balasubramaniam, S. D., Balakrishnan, V., Oon, C. E., & Kaur, G. (2019) · Medicina · doi:10.3390/medicina55070384 · Cited by 263
Metadata
- Authors
- He, C., Mao, D., Hua, G., Lv, X., Chen, X., Angeletti, P. C., Dong, J., Remmenga, S. W., Rodabaugh, K. J., Zhou, J., Lambert, P. F., Yang, P., Davis, J. S., & Wang, C.
- Venue
- EMBO Molecular Medicine
- Published
- 2015-09-28
- Volume
- 7
- Issue
- 11
- Pages
- 1426-1449
- ISSN
- 1757-4676 (ISSN-L)
- 1757-4684
- OpenAlex
- W2100761652
- Cited by
- 275
- References
- 78
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.